Get 50% OFF This Monsoon!
Nath Bio-Genes (India)
No Data Available
Investor Sentiment
Nath Bio-Genes (India) Share price and Fundamental Analysis
Key Metrics
Included In
Stock Returns
CAGR
Revenue Growth
Net Profit Growth
Operating Profit Growth
Dividend Growth
Stock Returns CAGR
Stock Heatmap
No Stocks
Smart Score
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
Technicals
Returns Calculator
If you would have investedResearch Report
No Research Report
Corporate Action
Financials
Key Ratios
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
Dividend History
5 Year FactSheet
Documents
No Data Available
News
Nath Bio-Genes (India) Management and History
Company Management
Unlock Management Data
See Detailed Analysis & Insights
Company History
Nath Bio-Genes (India) Limited was incorporated as 'Shivnath Farms Private Limited' on July 14, 1993 as a private limited company under the Companies Act, 1956. The company is engaged in the business of production, processing, and marketing of hybrid and GM seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The company has a pan India presence for sales through an extensive network of distributors.
In India, the company has nearly 16 business centres covering 131 territories & connecting with over 2,000 distributors, all across the country. The company has been presently venturing to newer geographies outside the country, possessing similar agronomical conditions as India. all set to spread its wings in other parts of Asia, Africa & the Middle East. The company has developed modern infrastructure facilities, biotech lab and seed technology lab. It has a wide dealers and distribution network of PAN India marketing & distribution network which is manned by technically and commercially skilled marketing team.
The Company produced several highly ranked cotton seeds in the country which have done well in the ICAR trials and stood the test of time with respect to various virus tolerance as well as improved yield in spite of weather fluctuations. It is the first seed company in Asia Pacific region to get ISO 9001 certificate. It's new launches Sanket and Daksh cotton seeds have been ranked among top 3 in most geographies and under various planting conditions. The consistent high rank achieved by company's new seeds gives reasonable confidence about it growing it's cotton seeds portfolio faster than the industry. The strategy is to provide farmers with a wide range of varieties of cotton seeds suitable for diverse climatic conditions while maintaining yield superiority.
The company has worked on de-risking it's business by having multiple growth drivers like paddy, vegetable seeds and plant nutrient in it's portfolio. The company established a network of over 15,000 farmers growing seeds. It has been awarded with the prestigious 'Vasantrao Naik Prathisthan Award' for its contribution for enhancing Agricultural Productivity amongst other rewards & recognition.
At present, the company has about 18 breeding and evaluation R&D Stations in different agro-climatic conditions. It has more than 300 acres of land dedicated to research and development, across the nation. It has collaboration with reputed International and National Centres of Excellence (NRCPB, CIMMYT, IRRI, ICRISAT Etc.) The company has a team of handpicked plant breeders and bio technologists, located at key R&D stations, across the country, guided by R&D veterans. It undertakes seed production in over 30,000 acres of land with about 25,000 loyal growers and 72 technically qualified organizers. The company assures that seeds of the highest quality reaches the processing centers by setting rigorous field standards and quality control checks throughout the seed production process.
The company has elaborate seed processing facilities with 10 Processing Plants located in Maharashtra and Andhra Pradesh. It has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis. The seeds received from growers are processed to achieve quality standards which surpass those prescribed by the regulatory authorities. All the plants are equipped with pre-cleaner, fine cleaner, grader, gravity separator, de-stoner, indented cylinder, treater, needle separator and packing machines which are fully automated. The company has independent facilities for ginning, de-linting, drying, processing, treating, packing and storage of seeds. The seed processing quality is taken to the next level by ensuring improvements in seed viability and prolonging the shelf life of seeds. All the packing material has best environmental barriers characteristics to guarantee optimal storage conditions for the seed.
The company's key function is to rigorously test products in various agro-climatic regions and compare the yield to benchmark products of competitors. The product undergoes a rigorous state gate screening process comprising six stages prior to commercial release. Seed Production and Disease Screening are an instrumental part of product development with testing spread across 40 locations, 8 centres and all agro-climatic zones of India. Besides, trials are conducted in three phases to thoroughly test the performance of products before recommending for a national launch. The three different phases of trials are MLT (Multi Location Trial), LST (Large scale Trial) and Demonstrations. For the Multi-level trials, the company have nearly eight stations - each at a different agro-climatic zone divided across the length and breadth of the country.
Nath Bio-Genes (India) Share Price
Nath Bio-Genes (India) share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Nath Bio-Genes (India) Market Cap
Market capitalization of Nath Bio-Genes (India) indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Nath Bio-Genes (India) is valued compared to its competitors.
Nath Bio-Genes (India) PE Ratio
Nath Bio-Genes (India) PE ratio helps investors understand what is the market value of each stock compared to Nath Bio-Genes (India) 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
Nath Bio-Genes (India) PEG Ratio
The PEG ratio of Nath Bio-Genes (India) evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Nath Bio-Genes (India) ROE (Return on Equity)
Return on Equity (ROE) measures how effectively Nath Bio-Genes (India) generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Nath Bio-Genes (India) ROCE (Return on Capital Employed)
Return on Capital Employed (ROCE) evaluates the profitability of Nath Bio-Genes (India) in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Nath Bio-Genes (India) Total Debt
Total debt of Nath Bio-Genes (India) shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
Nath Bio-Genes (India) Debt to Equity Ratio
The Debt-to-Equity (DE) ratio of Nath Bio-Genes (India) compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
Nath Bio-Genes (India) CAGR (Compound Annual Growth Rate)
CAGR shows the consistent growth rate of Nath Bio-Genes (India) over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Nath Bio-Genes (India) Technical Analysis
Technical analysis of Nath Bio-Genes (India) helps investors get an insight into when they can enter or exit the stock. Key components of Nath Bio-Genes (India) Technical Analysis include:
Support Levels (S1, S2, S3)
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
Resistance Levels (R1, R2, R3)
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Nath Bio-Genes (India) shares often struggle to rise above due to selling pressure.
Nath Bio-Genes (India) Dividends
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Nath Bio-Genes (India) ’s financial health and profitability.
Nath Bio-Genes (India) Bonus Shares
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Nath Bio-Genes (India) Stock Split
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
Nath Bio-Genes (India) Financials
The financials of Nath Bio-Genes (India) provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
Nath Bio-Genes (India) Profit and Loss Statements
The profit and loss statement of Nath Bio-Genes (India) highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Nath Bio-Genes (India) .
Nath Bio-Genes (India) Balance Sheet
The balance sheet presents a snapshot of Nath Bio-Genes (India) ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Nath Bio-Genes (India) Cashflow Statements
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App
SEBI REGISTERED RESEARCH ANALYST REGISTRATION NUMBER: INH000015729Disclaimer: "Investments in securities are subject to market risks. Read all the related documents carefully before investing." Receiving registration from SEBI and certification from NISM does not assure the performance of the intermediary or guarantee returns to investors in any manner. Compliance Email: [email protected]
Features
Portfolio Analysis
Screener
Stock compare
Buckets
Watchlist
Superstar Portfolio
Market
List of BSE200 Companies
List of NIFTY500 Companies
List of NIFTY NEXT 50 Companies
NIFTY Top gainers in 5 Days
NIFTY100 Most Active Stocks
NIFTY Top Gainers in 1 Month